These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 15477536)

  • 61. Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.
    Talbot K; Wang HY; Kazi H; Han LY; Bakshi KP; Stucky A; Fuino RL; Kawaguchi KR; Samoyedny AJ; Wilson RS; Arvanitakis Z; Schneider JA; Wolf BA; Bennett DA; Trojanowski JQ; Arnold SE
    J Clin Invest; 2012 Apr; 122(4):1316-38. PubMed ID: 22476197
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.
    Bomfim TR; Forny-Germano L; Sathler LB; Brito-Moreira J; Houzel JC; Decker H; Silverman MA; Kazi H; Melo HM; McClean PL; Holscher C; Arnold SE; Talbot K; Klein WL; Munoz DP; Ferreira ST; De Felice FG
    J Clin Invest; 2012 Apr; 122(4):1339-53. PubMed ID: 22476196
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Effects of Peripheral and Central High Insulin on Brain Insulin Signaling and Amyloid-β in Young and Old APP/PS1 Mice.
    Stanley M; Macauley SL; Caesar EE; Koscal LJ; Moritz W; Robinson GO; Roh J; Keyser J; Jiang H; Holtzman DM
    J Neurosci; 2016 Nov; 36(46):11704-11715. PubMed ID: 27852778
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Insulin signaling, glucose metabolism and mitochondria: major players in Alzheimer's disease and diabetes interrelation.
    Correia SC; Santos RX; Carvalho C; Cardoso S; Candeias E; Santos MS; Oliveira CR; Moreira PI
    Brain Res; 2012 Mar; 1441():64-78. PubMed ID: 22290178
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.
    Reger MA; Watson GS; Frey WH; Baker LD; Cholerton B; Keeling ML; Belongia DA; Fishel MA; Plymate SR; Schellenberg GD; Cherrier MM; Craft S
    Neurobiol Aging; 2006 Mar; 27(3):451-8. PubMed ID: 15964100
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Insulin resistance and Alzheimer's disease: molecular links & clinical implications.
    Neumann KF; Rojo L; Navarrete LP; Farías G; Reyes P; Maccioni RB
    Curr Alzheimer Res; 2008 Oct; 5(5):438-47. PubMed ID: 18855585
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer's-like changes.
    Gupta A; Bisht B; Dey CS
    Neuropharmacology; 2011 May; 60(6):910-20. PubMed ID: 21277873
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Insulin resistance is associated with the pathology of Alzheimer disease: the Hisayama study.
    Matsuzaki T; Sasaki K; Tanizaki Y; Hata J; Fujimi K; Matsui Y; Sekita A; Suzuki SO; Kanba S; Kiyohara Y; Iwaki T
    Neurology; 2010 Aug; 75(9):764-70. PubMed ID: 20739649
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
    Craft S; Baker LD; Montine TJ; Minoshima S; Watson GS; Claxton A; Arbuckle M; Callaghan M; Tsai E; Plymate SR; Green PS; Leverenz J; Cross D; Gerton B
    Arch Neurol; 2012 Jan; 69(1):29-38. PubMed ID: 21911655
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription.
    Chen Y; Zhou K; Wang R; Liu Y; Kwak YD; Ma T; Thompson RC; Zhao Y; Smith L; Gasparini L; Luo Z; Xu H; Liao FF
    Proc Natl Acad Sci U S A; 2009 Mar; 106(10):3907-12. PubMed ID: 19237574
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment.
    Craft S
    Curr Alzheimer Res; 2007 Apr; 4(2):147-52. PubMed ID: 17430239
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Body mass index in midlife and risk of Alzheimer disease and vascular dementia.
    Whitmer RA; Gunderson EP; Quesenberry CP; Zhou J; Yaffe K
    Curr Alzheimer Res; 2007 Apr; 4(2):103-9. PubMed ID: 17430231
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease.
    Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F
    Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434
    [TBL] [Abstract][Full Text] [Related]  

  • 74. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
    Castello MA; Soriano S
    Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.
    Craft S; Peskind E; Schwartz MW; Schellenberg GD; Raskind M; Porte D
    Neurology; 1998 Jan; 50(1):164-8. PubMed ID: 9443474
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.
    Moreira PI; Santos MS; Seiça R; Oliveira CR
    J Neurol Sci; 2007 Jun; 257(1-2):206-14. PubMed ID: 17316694
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Roles of glycogen synthase kinase 3 in Alzheimer's disease.
    Cai Z; Zhao Y; Zhao B
    Curr Alzheimer Res; 2012 Sep; 9(7):864-79. PubMed ID: 22272620
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.
    Rivera EJ; Goldin A; Fulmer N; Tavares R; Wands JR; de la Monte SM
    J Alzheimers Dis; 2005 Dec; 8(3):247-68. PubMed ID: 16340083
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review.
    de la Monte SM
    Eur Neuropsychopharmacol; 2014 Dec; 24(12):1954-60. PubMed ID: 25088942
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Risk of dementia in diabetes mellitus: a systematic review.
    Biessels GJ; Staekenborg S; Brunner E; Brayne C; Scheltens P
    Lancet Neurol; 2006 Jan; 5(1):64-74. PubMed ID: 16361024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.